Jhoana Quezada
Family · El Paso, TXNPI 1386287332
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,291 of the $10,027 with a category attached, or 62.7%. Viiv Healthcare Company accounts for 64.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $4,901 and has fallen 84.6% since, to $755 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 212 payments — averaging $47.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$6K
- Gilead$2K
- Merck$410
- Janssen Products, LP$216
- AbbVie$171
- Phathom Pharmaceuticals, Inc.$125
- plus $528 from 6 others
What the payments were for
- Consulting fees$3,00030%
- Travel & lodging$6086%
- Food & beverage$6,29163%
- Education$1271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 121 | $6,451 |
| Gilead | 48 | $2,126 |
| Merck | 21 | $410 |
| Janssen Products, LP | 2 | $216 |
| AbbVie | 4 | $171 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| AstraZeneca | 1 | $125 |
| Theratechnologies Inc. | 4 | $106 |
| Novo Nordisk | 1 | $100 |
| Johnson & Johnson(2 entities) | 5 | $88 |
| EMD Serono, Inc. | 2 | $58 |
| Astellas Pharma US Inc | 2 | $52 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,027 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 168 | $671,032 |
| DovatoDolutegravir Sodium/Lamivudine | 152 | $436,828 |
| RukobiaFostemsavir Tromethamine | 45 | $396,869 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 56 | $234,363 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 44 | $171,212 |
| JulucaDolutegravir/Rilpivirine | 34 | $125,407 |
| TivicayDolutegravir Sodium | 24 | $69,899 |
| CabenuvaCabotegravir/Rilpivirine | 11 | $67,731 |
| DescovyEmtricitabine/Tenofov Alafenam | 22 | $53,721 |
| PrezcobixDarunavir/Cobicistat | 18 | $45,075 |
| TrulicityDulaglutide | 12 | $11,681 |
| JardianceEmpagliflozin | 12 | $7,359 |
| Testosterone | 19 | $1,741 |
| Abacavir-LamivudineAbacavir Sulfate/Lamivudine | 12 | $1,225 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 29 | $431 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Viiv Healthcare CompanyDovato, Rukobia, Triumeq, Juluca, Tivicay | $6,451 | $1,331,096322 claims |
| GileadBiktarvy, Genvoya, Descovy | $2,126 | $895,966234 claims |
| Johnson & JohnsonPrezcobix | $88 | $45,07518 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 15,456 family providers in Texas.
Other family in El Paso
- Margarita FavelaEl Paso$73K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.